Evaluation of prognostic factors among patients with chronic

Patients’ characteristics. Jose A. Pérez-Simón et al. Haematologica 2012; 97: 11871195 © 2012 by

Chronic GVHD organ involvement. Jose A. Pérez-Simón et al. Haematologica 2012; 97: 11871195 ©

Characteristics of c. GVHD among patients with classic versus overlap syndrome. Jose A. Pérez-Simón

Univariate and multivariate analysis for c. GVHD related mortality. Jose A. Pérez-Simón et al.

Univariate and multivariate analysis for OS-c. GVHD. Jose A. Pérez-Simón et al. Haematologica 2012;

Landmark plots illustrating the impact of (A) the NIH severity score; (B) the ECOG

Landmark plot illustrating the impact of the new composite variable on the incidence of

(A) Overall survival from c. GVHD diagnosis for patients with 1– 3 versus ≥

(A) Overall survival from c. GVHD diagnosis for patients with mild, moderate or severe

Overall survival from c. GVHD diagnosis depending on the variable which resulted from combining

Slides: 11

Download presentation

Evaluation of prognostic factors among patients with chronic graft-versus-host disease by Jose A. Pérez-Simón, Gabriel Afram, Rodrigo Martino, Jose L Piñana, Teresa Caballero-Velazquez, Olle Ringden, David Valcarcel, Dolores Caballero, Mats Remberger, Yanira de Paz, Jordi Sierra, Jesús San Miguel, and Hans Hagglund haematol Volume 97(8): 1187 -1195 August 1, 2012 © 2012 by Ferrata Storti Foundation

Landmark plots illustrating the impact of (A) the NIH severity score; (B) the ECOG ≥ 2, 1 and 0 performance status; (C) the platelet count <100 and >100× 109/L; and (D) the severity of gut involvement on the incidence of c. GVHD-related mortality. Jose A. Pérez-Simón et al. Haematologica 2012; 97: 11871195 © 2012 by Ferrata Storti Foundation

Landmark plot illustrating the impact of the new composite variable on the incidence of c. GVHDrelated mortality. Jose A. Pérez-Simón et al. Haematologica 2012; 97: 11871195 © 2012 by Ferrata Storti Foundation

(A) Overall survival from c. GVHD diagnosis for patients with 1– 3 versus ≥ 4 organs involved (B) for patients with classic c. GVHD versus overlap syndrome and (C) for patients with delayed a. GVHD versus classic c. GVHD. Jose A. Pérez-Simón et al. Haematologica 2012; 97: 11871195 © 2012 by Ferrata Storti Foundation

(A) Overall survival from c. GVHD diagnosis for patients with mild, moderate or severe c. GVHD (B) for patients with ECOG 0, 1 and ≥ 2 (C) for patients with platelets <100 and >100× 109/L and (D) for patients with gut score 3, 2, 1 and 0. Jose A. Pérez-Simón et al. Haematologica 2012; 97: 11871195 © 2012 by Ferrata Storti Foundation

Overall survival from c. GVHD diagnosis depending on the variable which resulted from combining ECOG, platelets and gastrointestinal involvement. Jose A. Pérez-Simón et al. Haematologica 2012; 97: 11871195 © 2012 by Ferrata Storti Foundation